Trial intelligence / Profile preview

Preoperative Nerve Block for Sevoflurane Reduction in Shoulder Arthroplasty

NCT04020601Phase 3Terminated

Sponsor
University of Alberta
Start
Aug 2019
Primary completion
Mar 2020
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of ropivacaine in rotator cuff injury, sponsored by University of Alberta. Started Aug 2019; status: terminated.

02

Drugs

ropivacaine
03

Conditions

rotator cuff injury

Beyond the preview

Go deeper on NCT04020601.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04020601.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call